Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies.
Photodynamic therapy (PDT) is a binary treatment modality that has been used to treat malignant brain tumours for 25 years. The treatment involves the selective uptake of a photosensitizer (PS) by the tumour cells followed by irradiation of the tumour with light of the appropriate wavelength to excite and activate the PS resulting in selective tumour destruction and is a potentially valuable adjunct to surgical excision and other conventional therapies. PDT has undergone extensive laboratory studies and clinical trials with a variety of PS and tumour models. These are discussed with reference mainly to clinical studies involving the PDT of brain tumours.
Stylli
Stanley S
SS
Department of Neurosurgery, Department of Surgery, 5th Floor Clinical Sciences Building, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria 3052, Australia. stanley.stylli@mh.org.au
Kaye
Andrew H
AH
D000818:Animals; D001932:Brain Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D005910:Glioma / Q000628:therapy*; D006801:Humans; D010778:Photochemotherapy / Q000379:methods*